Log In
Print this Print this

NovoLog Mix 50/50 (NovoMix 50)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionMix of 50% insulin aspart protamine suspension and 50% insulin aspart injection
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsControl hyperglycemia in patients with diabetes; Treat diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today